A polyvalent vaccine for high-risk prostate patients: “are more antigens better?”.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 12, p. 1921, doi. 10.1007/s00262-007-0335-y
- By:
- Publication type:
- Article
Works by Diani, Meghan
Results: 3
1
2
Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 7, p. 694, doi. 10.1007/s00262-004-0598-5
- By:
- Publication type:
- Article
3
High-dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinoma.
- Published in:
- Cancer (0008543X), 2004, v. 100, n. 9, p. 1868, doi. 10.1002/cncr.20185
- By:
- Publication type:
- Article